Patents by Inventor Viki BOCKSTAL

Viki BOCKSTAL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Poxvirus vectors encoding HIV antigens, and methods of use thereof
    Patent number: 11723970
    Abstract: Poxvirus vectors encoding a synthetic HIV envelope antigen and other HIV antigens, as well as compositions containing such poxvirus vectors and uses of such poxvirus vectors as vaccines to provide improved immunity against HIV, are provided. Also provided are vaccine combinations containing the disclosed poxvirus vectors, adenovirus vectors encoding one or more HIV antigens, and one or more isolated HIV antigenic polypeptides, and methods of using the vaccine combinations to provide improved immunity against HIV.
    Type: Grant
    Filed: December 10, 2021
    Date of Patent: August 15, 2023
    Assignees: Janssen Vaccines & Prevention B. V., Bavarian Nordic A/S
    Inventors: Frank Wegmann, Johannes Petrus Maria Langedijk, Jerôme Hubertina Henricus Victor Custers, Viki Bockstal, Markus Kalla
  • Poxvirus Vectors Encoding HIV Antigens, and Methods of Use Thereof
    Publication number: 20220088172
    Abstract: Poxvirus vectors encoding a synthetic HIV envelope antigen and other HIV antigens, as well as compositions containing such poxvirus vectors and uses of such poxvirus vectors as vaccines to provide improved immunity against HIV, are provided. Also provided are vaccine combinations containing the disclosed poxvirus vectors, adenovirus vectors encoding one or more HIV antigens, and one or more isolated HIV antigenic polypeptides, and methods of using the vaccine combinations to provide improved immunity against HIV.
    Type: Application
    Filed: December 10, 2021
    Publication date: March 24, 2022
    Inventors: Frank Wegmann, Johannes Petrus Maria Langedijk, Jerôme Hubertina Henricus Victor Custers, Viki Bockstal, Markus Kalla
  • Poxvirus vectors encoding HIV antigens, and methods of use thereof
    Patent number: 11229693
    Abstract: Poxvirus vectors encoding a synthetic HIV envelope antigen and other HIV antigens, as well as compositions containing such poxvirus vectors and uses of such poxvirus vectors as vaccines to provide improved immunity against HIV, are provided. Also provided are vaccine combinations containing the disclosed poxvirus vectors, adenovirus vectors encoding one or more HIV antigens, and one or more isolated HIV antigenic polypeptides, and methods of using the vaccine combinations to provide improved immunity against HIV.
    Type: Grant
    Filed: June 14, 2018
    Date of Patent: January 25, 2022
    Assignees: Janssen Vaccines & Prevention B.V., Bavarian Nordic A/S
    Inventors: Frank Wegmann, Johannes Petrus Maria Langedijk, Jerôme Hubertina Henricus Victor Custers, Viki Bockstal, Markus Kalla
  • POXVIRUS VECTORS ENCODING HIV ANTIGENS, AND METHODS OF USE THEREOF
    Publication number: 20200138938
    Abstract: Poxvirus vectors encoding a synthetic HIV envelope antigen and other HIV antigens, as well as compositions containing such poxvirus vectors and uses of such poxvirus vectors as vaccines to provide improved immunity against HIV, are provided. Also provided are vaccine combinations containing the disclosed poxvirus vectors, adenovirus vectors encoding one or more HIV antigens, and one or more isolated HIV antigenic polypeptides, and methods of using the vaccine combinations to provide improved immunity against HIV.
    Type: Application
    Filed: June 14, 2018
    Publication date: May 7, 2020
    Inventors: Frank WEGMANN, Johannes Petrus Maria LANGEDIJK, Jerôme Hubertina Henricus Victor CUSTERS, Viki BOCKSTAL, Markus KALLA